Manhattan Scientifics Inc (MHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 329 | 278 | 561 | 362 | 626 |
| Marketable Securities | 97 | 151 | 215 | 151 | 215 |
| Other current assets | 0 | 43 | 0 | 0 | 0 |
| TOTAL | $446 | $502 | $833 | $596 | $841 |
| Non-Current Assets | |||||
| Investments And Advances | 2 | 2 | 2 | 2 | 2 |
| Intangibles | 265 | 273 | 282 | 290 | 268 |
| Other Non-Current Assets | 1 | 2 | 2 | 2 | 30 |
| TOTAL | $268 | $277 | $286 | $294 | $300 |
| Total Assets | $714 | $779 | $1,119 | $890 | $1,141 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 273 | 259 | 171 | 219 | 260 |
| Accrued Expenses | 604 | 561 | 517 | 491 | 545 |
| TOTAL | $1,990 | $1,848 | $1,845 | $1,738 | $1,833 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 85 | N/A | 129 | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,990 | $1,848 | $1,845 | $1,738 | $1,833 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 401,503 | 401,503 | 400,153 | 397,453 | 396,253 |
| Common Shares | 402 | 400 | 400 | 398 | 396 |
| Retained earnings | -53,894 | -53,594 | -53,281 | -53,089 | -52,831 |
| Other shareholders' equity | 112 | 151 | 215 | 151 | 215 |
| TOTAL | $-1,276 | $-1,069 | $-726 | $-848 | $-692 |
| Total Liabilities And Equity | $714 | $779 | $1,119 | $890 | $1,141 |